omeprazole has been researched along with famotidine in 204 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (6.37) | 18.7374 |
| 1990's | 89 (43.63) | 18.2507 |
| 2000's | 71 (34.80) | 29.6817 |
| 2010's | 25 (12.25) | 24.3611 |
| 2020's | 6 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamaru, M; Nakashima, M | 1 |
| Ogawa, N | 1 |
| Arisawa, T; Asai, J; Goto, H; Hase, S; Suzuki, T; Tsukamoto, Y | 1 |
| Halabi, A; Kirch, W | 1 |
| Alcón, A; Bisbe, E; Castaño, J; Escolano, F; López, R | 1 |
| Annibale, B; Cassetta, MR; Delle Fave, G; Franceschi, M; Quatrini, M; Torsoli, A | 1 |
| Babu, S; Chaubal, C; Kumar, TR; Naidu, MU; Prasad, R; Reddy, DN; Shobha, JC; Subhash, S | 1 |
| Gardner, JD; Jensen, RT; Maton, PN; Metz, DC; Norton, JA; Pisegna, JR; Slimak, GG | 1 |
| Grymbowski, T; Hennig, U; Hotz, J; Kleinert, R; Schwarz, JA | 1 |
| Battaglia, G; Cammelli, F; Lualdi, M; Pesci, M; Seveso, M; Vimercati, C | 1 |
| Guram, M; Holt, S; Howden, CW | 1 |
| Fennerty, MB; Sampliner, RE | 1 |
| Bräuer, U; Kromer, W; Postius, S | 1 |
| Inatomi, N; Nagaya, H; Satoh, H | 1 |
| Inatomi, N; Nagaya, H; Satoh, H; Shino, A; Takami, K | 1 |
| Bianchi-Porro, G; Bonavina, L; Pace, F; Peracchia, A; Sangaletti, O; Termini, R; Vigneri, S | 1 |
| Horikoshi, T; Kobayashi, S; Kusano, M; Matsuzaki, T; Nishioka, T; Ohwada, T; Sekiguchi, T; Sugiyama, M; Toki, M | 1 |
| Amoruso, A; Barone, M; Di Leo, A; Francavilla, A; Ingrosso, M; Makowka, L; Panella, C; Polimeno, L; Starzl, TE | 1 |
| Davis, MA; Decktor, DL; Kellner, AT; Pendleton, RG | 1 |
| De Natale, F; De Natale, G; Marino, A | 1 |
| Gardner, JD; Jensen, RT; Maton, PN | 1 |
| Fabian, MA; Fabri, PJ; Gower, WR; Knierim, TH | 1 |
| Itoh, H; Ono, T; Shibayama, F; Tomoi, M; Ueda, S | 1 |
| Cook, PG; Mangel, AW; Pendleton, RG; Shepherd-Rose, A | 1 |
| Mahachai, V; Thomson, AB | 1 |
| Asano, K; Haga, K; Maruyama, Y; Osuga, K | 1 |
| Gugler, R | 2 |
| Asaki, S; Hongo, M; Motojima, T; Ohara, S; Ohara, T; Sato, A; Sato, H; Shibuya, D; Tamura, T; Yamaguchi, N | 1 |
| Burget, DW; Howden, CW; Hunt, RH; Jones, DB | 1 |
| Andrews, P; Bae, H; Borody, TJ; Brandl, S; Fracchia, G; Shortis, NP | 1 |
| Akuzawa, S; Ito, H; Kamato, T; Kobayashi-Uchida, A; Nagakura, Y; Nishida, A; Shishido, T; Takinami, Y; Yamano, M; Yuki, H | 1 |
| Carrasquer, G; Geng, Z; Rehm, WS; Schilb, TP; Schwartz, M | 1 |
| Goto, H; Hamajima, E; Hoshino, H; Ozawa, T; Sugiyama, S; Tsukamoto, Y | 1 |
| Fukuda, M; Higashi, T; Imaizumi, T; Kawano, S; Miura, N; Miyajima, K; Mukuda, T; Noguchi, M; Tatsumi, T; Tsuji, S | 1 |
| Ashida, K; Katsu, K; Miyoshi, H; Sakaguchi, M; Umegaki, E | 1 |
| Motoo, Y; Okai, T; Sawabu, N; Songür, Y; Watanabe, H | 1 |
| Fukuchi, S; Hashimoto, M; Hoshihara, Y; Iguchi, D; Kimura, T; Sugawara, K; Takemoto, T; Tanaka, T; Yamamoto, T | 2 |
| Asagoe, K; Dekigai, H; Kusaka, S; Maeda, S; Matsumoto, M; Mizuno, M; Murakami, M; Saita, H; Seki, M; Takahashi, Y | 1 |
| Hanson, DG; Kahrilas, PJ; Kamel, PL | 1 |
| Maculotti, L; Pradella, P | 1 |
| Hoshino, E; Miki, K; Umeda, N | 1 |
| Asaka, M; Hokari, K; Takeda, H | 1 |
| Echevarria, V; Espachs, P; Garcia, M; Rincón, R; Vidal, F; Vila, P | 1 |
| Chiba, T; Chihara, K; Kinoshita, Y; Yamashita, Y | 1 |
| Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ | 1 |
| Dominguez, HL; Freston, JW | 1 |
| Goh, KL; Parasakthi, N | 1 |
| Chijiiwa, Y; Maruoka, A; Nawata, H; Tanaka, M | 1 |
| Arizón Deza, P; García Tenorio, A; Gonzalo Til, A; Manero Ruiz, I; Mur Lalueza, MJ; Pascual Parrilla, MS | 1 |
| Fujihara, A; Kamato, T; Miyata, K; Nishida, A; Takeda, M; Yuki, H | 1 |
| Fujimoto, K; Iwakiri, R; Koyama, T; Mizuguchi, M; Ohyama, T; Sakata, H; Tanaka, J; Tokunaga, O | 1 |
| Besancon, M; Helander, H; Sachs, G; Scott, DR | 1 |
| Akuzawa, S; Ito, H; Kamato, T; Kobayashi, A; Miyata, K; Nagakura, Y; Nishida, A; Takinami, Y; Yamano, M; Yuki, H | 1 |
| Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F | 1 |
| Blanloeil, Y; Boulay, K; Bourveau, M; Geay, G; Malinovsky, JM | 1 |
| Bhasin, DK; Khosla, PP; Sachdev, A; Saha, N; Sankaranahyanan, A; Sharma, PL; Singh, K | 1 |
| Davis, RL; Egli, D; Hashimoto, F | 1 |
| Busam, J; Garbe, WE | 1 |
| Colin, R; Cortot, A; Ducrotté, P; Elouaer-Blanc, L; Guillemot, F; Hirschauer, C; Hochain, P; Michel, P; Petit, A; Thorel, JM | 1 |
| Dasarathy, S; Misra, SC; Sharma, MP | 1 |
| Haruma, K; Kajiyama, G; Sachs, G; Sumii, K; Sumii, M; Takehara, Y; Tari, A; Walsh, JH; Wu, V; Yamamoto, G | 1 |
| Sakaki, N; Takemoto, T | 1 |
| Carrasquer, G; Rehm, WS; Schwartz, M; Wu, X; Zhang, JY | 1 |
| Arakawa, T; Higuchi, K; Kobayashi, K; Oshitani, N; Yamada, T | 1 |
| Annibale, B; Cassetta, MR; Corleto, V; D'Ambra, G; Delle Fave, G; Ferrua, B; Saggioro, A | 1 |
| Aono, T | 1 |
| Agostini, H; Lemaire, M; Poynard, T | 1 |
| Gomez, G; Greeley, GH; Padilla, L; Sundler, F; Tarasova, N; Thompson, JC; Townsend, CM; Udupi, V | 1 |
| Inada, I; Satoh, H | 1 |
| Chuah, SY; Goh, KL; Lo, YL; Navaratnam, P; Peh, SC; Rahman, NA; Wong, NW | 1 |
| Chakrabarti, A; Goenka, MK; Gupta, O; Kochhar, R; Kumar, A; Mehta, SK; Talwar, P | 1 |
| Guslandi, M | 1 |
| Boland, CR; Delbarre, SG; Kraus, E; Yoshimura, K | 1 |
| Asano, S; Inatomi, N; Murakami, I; Nagaya, H; Satoh, H; Yukishige, K | 1 |
| Asano, S; Inada, I; Inatomi, N; Murakami, I; Satoh, H | 1 |
| Chen, TL; Hsu, HW; Huang, CL; Lin, CJ | 1 |
| Berstad, A; Hatlebakk, JG | 1 |
| Altschul, M; Cummings, JF; Dykes, NL; Mauldin, EA; Reubi, JC; Simpson, KW | 1 |
| Itoh, T; Kamisaki, Y; Kawasaki, H; Kishimoto, Y; Kitano, M; Nakamoto, K; Wada, K | 1 |
| Moayyedi, P | 1 |
| Florholmen, J; Løvhaug, N; Støa-Birketvedt, G; Vonen, B | 1 |
| Hibi, T; Ishii, H; Iwai, N; Miyayama, A; Mori, M; Oonuki, M; Suzuki, H; Suzuki, M; Tsunematsu, N | 1 |
| Haga, Y; Nakamura, Y; Nakatsura, T; Ogawa, M; Sameshima, H; Shibata, Y; Tanimura, M | 1 |
| Brown, KL; Fisher, RS; Knight, LC; Maurer, AH; Miller, MA; Parkman, HP; Trate, DM; Urbain, JL | 1 |
| Goral, V; Inalöz, SS; Sari, I | 1 |
| Alm, C; Grahnén, A; Hedenström, H; Kraft, M | 1 |
| Chan, CK; Cheung, E; Ching, TY; Chu, KM; Kong, Y; Kou, M; Kumana, CR; Lam, SK; Seto, WH | 1 |
| Arai, H; Inoie, M; Marubuchi, S | 1 |
| Kanayama, S | 1 |
| Armstrong, D; Lad, R | 1 |
| Saika, M; Senba, E; Ueyama, T | 1 |
| Jacoby, EB; Porter, KB | 1 |
| Fujimoto, S; Fujita, T; Kodama, Y; Kutsumi, H; Matsuura, M; Nishimura, K; Sekimoto, I; Soga, T; Yoshida, S | 1 |
| Sugano, K | 1 |
| Itoh, M; Joh, T; Kurokawa, T; Sasakii, M; Seno, K; Tsuchida, K; Yokoyama, Y | 1 |
| Berstad, A; Hatlebakk, JG; Olafsson, S; Wilhelmsen, I | 1 |
| Brandstätter, G; Dragosics, B; Gschwantler, M; Hentschel, E; Hirschl, AM; Klimpfinger, M; Oberhuber, G; Pasching, E; Schütze, K; Weiss, W; Wimmer, M; Wurzer, H | 1 |
| Abidin, ZU; Ivashkin, VT; Okhlobystin, AV; Sheptulin, AA; Trukhmanov, AS | 1 |
| Dave, B; Rubin, W | 1 |
| Martin, P; McKeand, W; Ohning, G; Paul, J; Pisegna, JR; Walsh, JH | 1 |
| Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M | 1 |
| Aibe, T; Eto, S; Fujisaki, T; Iida, T; Matsuoka, H; Mine, S; Morimoto, I; Tabata, T; Tanaka, Y; Yamada, S | 1 |
| Fujita, N; Kassai, K; Kondo, M; Naito, Y; Tanaka, Y; Yoshida, N; Yoshikawa, T | 1 |
| Endo, M; Sugihara, K | 1 |
| Mashiba, H; Matsumura, N; Okamoto, S; Sasaki, N; Taniyama, K; Uemura, N; Yamaguchi, S; Yamamoto, S | 1 |
| Arbak, S; Ayanoğlu-Dülger, G; Hürdağ, C; Paskaloğlu, K; Sener-Muratoğlu, G | 1 |
| Ivashkina, TG; Kulikov, AN; Malov, IuS | 1 |
| Miehsler, W; Oberhuber, T; Püspök, A; Vogelsang, H | 1 |
| Changchien, CS; Chen, JJ; Hsu, CC; Hu, TH; Lu, SN | 1 |
| Golochalova, TV; Gorbakov, VV; Makarov, IuS; Mironenko, DA; Rakov, AL | 1 |
| Akcay, MF; Banoglu, ZN; Büyükokuroglu, ME; Demirezer, LO; Gepdiremen, A; Göçer, F; Süleyman, H | 1 |
| Mutoh, H; Sugano, K | 1 |
| Ahmed, F; Castell, DO; Katz, PO; Korn, S; Tutuian, R | 1 |
| Furuta, T; Hanai, H; Ishizaki, T; Kajimura, M; Ohashi, K; Shirai, N; Xiao, F | 1 |
| Aoyagi, K; Esaki, M; Fujishima, M; Kuwano, Y; Matsumoto, T; Shimizu, M | 1 |
| Matsuno, K; Okabe, S; Tomita, K | 1 |
| Matsuoka, T; Miyazawa, K; Mizokami, Y; Nakamura, H; Narushima, K; Otsubo, T; Shiraishi, T | 1 |
| Muravtseva, OV; Vakhrushev, IaM | 2 |
| Abe, K; Adachi, K; Hamamoto, N; Ishihara, S; Kawashima, K; Kawauchi, H; Kinoshita, Y; Mak, R; Moritani, M; Oshima, N; Sato, H | 1 |
| Shcherbynina, MB | 1 |
| Iishi, H; Ikeda, M; Kanda, T; Kaneko, A; Kashio, S; Kawano, S; Kubo, M; Masuda, E; Murata, H; Noguchi, M; Sato, T; Tatsuta, M; Tsuji, S; Yoshihara, H | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, AM; Wong, PN | 1 |
| Fukao, K; Homma, M; Itagaki, F; Kohda, Y; Yuzawa, K | 1 |
| Grinevich, VB; Sablin, OA; Uspenskiĭ, IuL | 1 |
| Adachi, K; Fujishiro, H; Kinoshita, Y; Komazawa, Y; Mihara, T | 1 |
| Chan, CC; Chen, TK; Lee, CL; Liao, CC; Liu, CC; Tu, TC; Wu, CH | 1 |
| Abe, Y; Chiguchi, G; Inamori, M; Kawamura, H; Kikuchi, T; Kirikoshi, H; Kobayashi, N; Muramatsu, K; Nakajima, A; Sakaguchi, T; Sekihara, H; Takamura, T; Togawa, J; Ueno, N | 1 |
| Ishihara, S; Kinoshita, Y | 1 |
| Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S | 1 |
| Habu, Y; Hayakumo, T; Kawai, K; Shio, S; Yoshino, T | 1 |
| Demir, N; Demir, Y; Nadaroğlu, H | 1 |
| Iakovenko, AV; Iakovenko, EP; Ivanov, AN | 1 |
| Osipenko, MF; Venzhina, IuIu | 1 |
| Abe, Y; Chiguchi, G; Inamori, M; Kawamura, H; Kikuchi, T; Kirikoshi, H; Kobayashi, N; Muramatsu, K; Nakajima, A; Sakaguchi, T; Shimamura, T; Takamura, T; Togawa, J; Ueno, N | 1 |
| Coursol, CJ; Sanzari, SE | 1 |
| Allen, DG; Bersenas, AM; Conlon, PD; Mathews, KA | 1 |
| Scarpignato, C | 1 |
| Furuta, T; Hishida, A; Ishizaki, T; Kajimura, M; Nakamura, A; Ohashi, K; Shirai, N; Sugimoto, M | 1 |
| Fujita, F; Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kubota, E; Mori, Y; Nakao, H; Ogasawara, N; Ohara, H; Oshima, T; Sasaki, M; Sobue, S; Tanida, S; Togawa, S; Wada, T; Yamada, T | 1 |
| Arakawa, T; Chono, S; Fujiwara, Y; Higuchi, K; Kitada, K; Kobayashi, K; Nakagawa, K; Nebiki, H; Oshitani, N; Satoh, H; Tominaga, K; Uno, H; Watanabe, T | 1 |
| Futagami, S; Hiratsuka, T; Kusunoki, M; Miyake, K; Nakajima, A; Nishigaki, H; Sakamoto, C; Shinji, Y; Suzuki, K; Tatsuguchi, A; Tsukui, T; Ueki, N; Wada, K; Yoshino, S | 1 |
| Aoki, R; Chayama, K; Dongmei, Q; Hamada, H; Haruma, K; Hata, J; Hidaka, T; Kamada, T; Kido, S; Komoto, K; Kusunoki, H; Nishida, T; Ogoshi, H; Sanuki, E; Sumii, K; Sumioka, M; Tanimoto, T; Todo, H | 1 |
| Aoki, K; Ishida, H; Katsumi, N; Miura, M; Morita, Y; Morozumi, K; Nakamura, K; Takahashi, S; Tauchi, M; Toki, M; Yamaguchi, Y | 1 |
| Furuta, T; Hishida, A; Kajimura, M; Nakamura, A; Okudaira, K; Shirai, N; Sugimoto, M | 1 |
| Adachi, K; Amano, Y; Fujishiro, H; Furuta, K; Hashimoto, T; Hattori, S; Ishihara, S; Kinoshita, Y; Komazawa, Y; Mihara, T | 1 |
| de la Fuente, SG; Fujino, K; Mantyh, CR; Takahashi, T; Takami, Y | 1 |
| Evseev, MA; Gostishchev, VK | 1 |
| Iida, T; Kishikawa, H; Mine, S; Tabata, T; Tanaka, Y | 1 |
| Hashimoto, H; Hirota, K; Kudo, M; Kushikata, T | 1 |
| Bektaş, M; Cetinkaya, H; Ozden, A; Soykan, I; Törüner, M | 1 |
| Amagase, K; Fujimura, T; Kotani, T; Okabe, S; Takeuchi, K | 1 |
| Furuta, T; Miura, S; Okudaira, K; Shirai, N; Sugimoto, M | 1 |
| Bozkurt, B; Demirkan, K; Kalyoncu, AF; Karakaya, G | 1 |
| Gon, S; Irie, Y; Takahashi, M | 1 |
| Cheon, JH; Choi, KD; Jung, HC; Kim, JS; Kim, SG; Song, IS; Ye, BD | 1 |
| Horikawa, Y; Itoh, H; Jin, M; Komatsu, K; Konishi, N; Matsuhashi, T; Odashima, M; Ohba, R; Otaka, M; Wada, I; Watanabe, S | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Shirai, N; Sugimoto, M | 1 |
| Esplugues, JV; Martí-Cabrera, M; Ponce, J | 1 |
| Ikawa, K; Inoue, M; Kuroiwa, T; Morikawa, N; Moriwaki, M; Shimatani, T; Tazuma, S; Xu, J | 1 |
| Allgood, LD; Grender, JM; Miner, PB | 1 |
| Malur, PR; Patil, PA; Rao, KS | 1 |
| Beketov, AS; Belousov, DIu; Belousov, IuB; Karpov, OI | 1 |
| Fändriks, L; Lönroth, H; Pettersson, A; Vakil, N | 1 |
| Adachi, K; Fujimoto, K; Fujimura, Y; Fujisawa, T; Fuyuno, S; Haruma, K; Hori, K; Kido, S; Kin, Y; Kinoshita, Y; Kobori, M; Kusaka, M; Kusunoki, H; Matsunobu, A; Miwa, H; Nakamura, Y; Ono, N; Oza, N; Sugimoto, K; Tano, N; Tomita, T; Watanabe, Y; Yamauchi, R; Yuki, M | 1 |
| Evseev, MA; Golovin, RA; Ivakhov, GB | 1 |
| Amagase, K; Kato, S; Ochi, A; Sugihara, T; Takeuchi, K | 1 |
| Caínzos-Romero, T; Fernández-Fernández, FJ; Ferreira, L; Sesma, P | 1 |
| Caínzos-Romero, T; Fernández-Fernández, FJ; Ferreira-González, L; Sesma, P | 1 |
| Hiraishi, H; Kanke, K; Maeda, M; Sasai, T; Shimada, T | 1 |
| Aihara, E; Demitrack, ES; Kenny, S; Montrose, MH; Varro, A | 1 |
| Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B | 1 |
| McColl, KE | 1 |
| Ariyama, S; Kani, K; Kato, S; Kawashima, J; Ohno, S; Sakurada, T; Takabayashi, H; Yakabi, K | 1 |
| Hashimoto, E; Izuhara, C; Kaneko, S; Takayama, S; Takeuchi, K; Yamada, N; Yamanaka, S | 1 |
| Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T | 1 |
| Akiyama, J; Araki, A; Fujimoto, K; Fujimura, T; Fujioka, Y; Habu, Y; Harada, R; Haruma, K; Inoue, K; Kinoshita, Y; Kusaka, M; Mabe, K; Miwa, H; Miwa, J; Nagahara, A; Nagami, H; Oumi, T; Sakurai, K; Satoh, K; Shigeto, N; Suzuki, J; Suzuki, T; Tano, N | 1 |
| Hauso, Ø; Waldum, HL | 1 |
| Endo, T; Fukui, K; Hibi, K; Himeno, H; Kimura, K; Morita, S; Sugano, T; Tsukahara, K; Umemura, S; Yano, H | 1 |
| Czimmer, J; Mózsik, G; Szabó, IL; Szolcsányi, J | 1 |
| Horiuchi, H | 1 |
| Abramowitz, Y; Arbel, Y; Banai, S; Berliner, S; Birati, EY; Deutsch, V; Finkelstein, A; Halkin, A; Herz, I; Keren, G; Kletzel, H | 1 |
| Chan, HH; Chen, WC; Cheng, JS; Chiang, PH; Lai, KH; Li, YD; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, EM | 1 |
| Chang, YW; Choi, MG; Chun, HJ; Han, SW; Jeong, HY; Jung, HC; Jung, HY; Jung, JT; Kim, EH; Kim, HS; Kim, HY; Kim, JG; Lee, DH; Lee, OJ; Lee, ST; Lee, SW; Lee, YC; Park, JJ; Park, SH; Seol, SY; Youn, SJ | 1 |
| Brand, M; Davidson, G; Messenger, K; Odunayo, A; Papich, MG; Parkinson, S; Peters, E; Reed, A; Tolbert, K | 1 |
| Boulton, DW; Ren, S | 1 |
| Anderson, K; Cuvin, J; Kotecha, M; Namour, F; Qin, AR; Scott, B; Sharma, S; Xin, Y; Zheng, H | 1 |
| Chen, WC; Cheng, JS; Chuah, SK; Hsu, PI; Kao, SS; Peng, NJ; Shie, CB; Tang, SY; Tsai, KF; Tsay, FW; Tseng, ZF | 1 |
| Balaji, U; Chang, Y; Gu, J; Nelson, M; Odiase, E; Pan, Z; Souza, RF; Spechler, SJ; Zhang, Q; Zhang, X | 1 |
| Fass, R; Ganocy, SJ; Kim, YD; Poels, KE; Shibli, F; Wang, J | 1 |
| Fulkerson, CM; Moore, GE; Shaevitz, MH | 1 |
| Galyon, G; Hecht, S; Odunayo, A; Price, J; Tolbert, MK | 1 |
| D'Andrea, E; Desai, RJ; Feldman, WB; Lin, KJ; Liu, J; Pramod Umarje, S; Tesfaye, H; Wang, SV; Zabotka, LE | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
16 review(s) available for omeprazole and famotidine
| Article | Year |
|---|---|
[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Peptic Ulcer; Pirenzepine; Ranitidine; Thiazoles | 1989 |
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Topics: Cimetidine; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Nizatidine; Omeprazole; Parasympatholytics; Ranitidine; Thiazoles; Zollinger-Ellison Syndrome | 1989 |
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles | 1987 |
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Time Factors; Wound Healing | 1995 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
[Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1999 |
Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Gastric Juice; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer | 1999 |
[Duodenal ulcer].
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Japan; Male; Omeprazole; Prognosis; Sex Factors; Time Factors | 2002 |
[Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Markov Chains; Meta-Analysis as Topic; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Randomized Controlled Trials as Topic | 2004 |
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Esophagitis, Peptic; Famotidine; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Quality of Life | 2005 |
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic | 2005 |
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Famotidine; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Skin Tests | 2006 |
[Safety of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors | 2006 |
[Strategy to manage low dose aspirin-induced gastrointestinal injury].
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Famotidine; Gastric Mucosa; Humans; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Proton Pump Inhibitors; Ticlopidine | 2011 |
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
77 trial(s) available for omeprazole and famotidine
| Article | Year |
|---|---|
[Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Famotidine; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Lansoprazole; Middle Aged; Omeprazole; Stomach Ulcer | 1992 |
Cardiovascular effects of omeprazole and famotidine.
Topics: Aged; Cardiac Output; Double-Blind Method; Dyspepsia; Famotidine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Omeprazole; Stroke Volume | 1992 |
Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Famotidine; Female; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Premedication; Ranitidine | 1992 |
Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Evaluation Studies as Topic; Famotidine; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole | 1992 |
Comparative study of omeprazole and famotidine in the treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Humans; Male; Middle Aged; Omeprazole; Smoking | 1992 |
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Dose-Response Relationship, Drug; Duodenal Neoplasms; Famotidine; Female; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastrinoma; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Postoperative Period; Prospective Studies; Ranitidine; Sex Factors; Time Factors; Zollinger-Ellison Syndrome | 1992 |
Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Recurrence | 1992 |
[Comparative study of the effects of famotidine and omeprazole in the prevention of the aspiration of gastric contents syndrome in elective surgery].
Topics: Famotidine; Humans; Intraoperative Complications; Omeprazole; Pneumonia, Aspiration | 1992 |
High-dose famotidine in the maintenance treatment of refractory esophagitis: results of a "medium-term" open study.
Topics: Adult; Double-Blind Method; Esophagitis; Esophagoscopy; Famotidine; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Time Factors | 1991 |
Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline | 1995 |
Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Famotidine; Female; Fibroblast Growth Factor 2; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach; Stomach Ulcer | 1995 |
Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer | 1995 |
Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Famotidine; Female; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Ulcer; Ultrasonography | 1995 |
Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Regeneration; Stomach Ulcer | 1995 |
Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1995 |
[Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Topics: Duodenal Ulcer; Famotidine; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine | 1995 |
Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Cross-Over Studies; Endoscopy, Digestive System; Esophagitis, Peptic; Famotidine; Female; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Retrospective Studies | 1995 |
Acid aspiration prophylaxis in elective biliary surgery. A comparison of omeprazole and famotidine using manually aided gastric aspiration.
Topics: Adult; Aged; Biliary Tract Surgical Procedures; Elective Surgical Procedures; Famotidine; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Premedication; Suction | 1994 |
[Comparison of the effects between standard doses of H2-blocker (famotidine 20mg b.d.) and proton pump inhibitor (omeprazole 20mg o.d.) in the treatment of refractory reflux esophagitis by ambulatory 24-hr intra-gastroesophageal pH monitoring].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Esophagitis, Peptic; Esophagus; Famotidine; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Omeprazole | 1994 |
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia.
Topics: Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Microbial Sensitivity Tests; Omeprazole | 1995 |
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN | 1994 |
Effects of oral ranitidine, famotidine and omeprazole on gastric volume and pH at induction and recovery from general anaesthesia.
Topics: Administration, Oral; Adult; Aged; Anesthesia, General; Elective Surgical Procedures; Famotidine; Gastric Juice; Humans; Hydrogen-Ion Concentration; Middle Aged; Omeprazole; Pneumonia, Aspiration; Postoperative Complications; Preanesthetic Medication; Ranitidine | 1994 |
Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Topics: Adult; Cimetidine; Drug Hypersensitivity; Dyspepsia; Famotidine; Female; Histamine; Histamine H2 Antagonists; Humans; India; Male; Middle Aged; Omeprazole; Ranitidine | 1993 |
Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
Topics: Absenteeism; Adult; Analgesics; Antacids; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pain; Recurrence; Wound Healing | 1993 |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome; Wound Healing | 1996 |
Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole.
Topics: Adult; Anti-Ulcer Agents; Candidiasis; Cimetidine; Duodenal Diseases; Duodenal Ulcer; Famotidine; Female; Gastric Acidity Determination; Humans; Male; Omeprazole; Prospective Studies | 1996 |
Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
Topics: Administration, Oral; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anti-Ulcer Agents; Cesarean Section; Double-Blind Method; Famotidine; Female; Humans; Omeprazole; Pneumonia, Aspiration; Pregnancy; Ranitidine | 1996 |
Quadruple therapy: the golden bullet or a drug too far?
Topics: Antacids; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Patient Dropouts; Peptic Ulcer; Proton Pump Inhibitors; Research Design; Tetracycline; Time Factors; Treatment Outcome | 1996 |
Effect of gastric acid suppressants on human gastric motility.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Cross-Over Studies; Electromyography; Famotidine; Female; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Histamine H2 Antagonists; Humans; Male; Manometry; Omeprazole; Postprandial Period; Radionuclide Imaging; Ranitidine; Stomach | 1998 |
Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Capsules; Cross-Over Studies; Drug Administration Schedule; Famotidine; Fasting; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine; Solubility; Tablets; Time Factors | 1997 |
Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
Topics: Alcohol Drinking; Case-Control Studies; Endoscopy, Digestive System; Enzyme Inhibitors; Esophagitis, Peptic; Famotidine; Female; Follow-Up Studies; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Treatment Outcome | 1999 |
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Multivariate Analysis; Nizatidine; Omeprazole; Patient Dropouts; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Treatment Outcome | 1999 |
On demand therapy of reflux oesophagitis--a prospective study of symptoms, patient satisfaction and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Gastric Acidity Determination; Heartburn; Humans; Male; Middle Aged; Norway; Omeprazole; Patient Satisfaction; Prospective Studies; Quality of Life; Ranitidine; Socioeconomic Factors | 1999 |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Stomach Ulcer | 1999 |
Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Chronic Disease; Colonic Diseases, Functional; Diarrhea; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1999 |
Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome | 1999 |
Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Double-Blind Method; Endosonography; Enzyme Inhibitors; Esophagitis, Peptic; Esophagus; Famotidine; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mucous Membrane; Muscle, Smooth; Omeprazole; Proton Pump Inhibitors | 2000 |
[Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Drug Resistance; Enzyme Inhibitors; Esophagitis, Peptic; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Long-Term Care; Omeprazole; Proton Pump Inhibitors | 2000 |
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Topics: Anti-Ulcer Agents; Enzyme Inhibitors; Famotidine; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Neutrophil Infiltration; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Stomach | 2000 |
Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole | 2001 |
[Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Famotidine; Gastric Juice; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Middle Aged; Monitoring, Physiologic; Omeprazole; Rabeprazole | 2001 |
Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
Topics: Adult; Aged; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nonprescription Drugs; Omeprazole | 2002 |
Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans.
Topics: Aged; Anti-Ulcer Agents; Endoscopy; Famotidine; Female; Fibroblast Growth Factor 2; Humans; Male; Middle Aged; Omeprazole; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome; Wound Healing | 2002 |
Randomized comparative study of omeprazole and famotidine in reflux esophagitis.
Topics: Aged; Drug Evaluation; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Famotidine; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Random Allocation; Treatment Outcome | 2002 |
[Acid-base blood balance in patients with ulcer under treatment by the gastric secretion inhibitors and antacids].
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aluminum Compounds; Antacids; Duodenal Ulcer; Famotidine; Gastric Juice; Gastric Mucosa; Humans; Male; Omeprazole; Phosphates | 2002 |
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Anti-Ulcer Agents; Breath Tests; False Negative Reactions; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Piperidines; Predictive Value of Tests; Quinolones; Urea | 2003 |
Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Breath Tests; Carbolines; Clarithromycin; Drug Therapy, Combination; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Secondary Prevention; Treatment Outcome | 2003 |
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole | 2004 |
[Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
Topics: Drug Administration Schedule; Endoscopy, Digestive System; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2004 |
Impact of stress ulcer prophylaxis algorithm study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Ulcer Agents; Drug Administration Schedule; Famotidine; Female; Humans; Intensive Care Units; International Normalized Ratio; Male; Middle Aged; Omeprazole; Peptic Ulcer; Risk Factors | 2005 |
Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Circadian Rhythm; Cytochrome P-450 CYP2C19; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Female; Gastric Acid; Genotype; Histamine H2 Antagonists; Humans; Male; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton-Translocating ATPases; Rabeprazole | 2005 |
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Topics: Analysis of Variance; Anti-Ulcer Agents; Drug Therapy, Combination; Famotidine; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2005 |
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Topics: Anti-Ulcer Agents; Famotidine; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Hernia, Hiatal; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2005 |
Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Famotidine; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2005 |
Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Ulcer Agents; Blood Transfusion; Endoscopy, Gastrointestinal; Famotidine; Female; Hemostasis, Endoscopic; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Secondary Prevention; Treatment Outcome | 2005 |
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Topics: Aged; Anti-Ulcer Agents; Cost-Benefit Analysis; Endoscopy, Gastrointestinal; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Omeprazole; Postoperative Hemorrhage; Prospective Studies; Stomach Neoplasms; Stomach Ulcer | 2005 |
Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Famotidine; Female; Gastric Acid; Genotype; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole | 2005 |
Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Comorbidity; Cross-Over Studies; Drug Tolerance; Famotidine; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Middle Aged; Omeprazole; Pain Measurement; Prospective Studies; Proton Pump Inhibitors | 2005 |
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Endosonography; Enzyme Inhibitors; Esophagitis, Peptic; Famotidine; Female; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quality of Life; Recurrence; Treatment Outcome | 2005 |
The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Stomach; Treatment Outcome | 2004 |
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
Topics: Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Iatrogenic Disease; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2006 |
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.
Topics: Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Mixed Function Oxygenases; Omeprazole; Single-Blind Method; Time Factors | 2006 |
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Circadian Rhythm; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Genotype; Helicobacter pylori; Humans; Mixed Function Oxygenases; Omeprazole; Prospective Studies; Reference Values; Time Factors; Treatment Outcome | 2007 |
Can famotidine and omeprazole be combined on a once-daily basis?
Topics: Adult; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Humans; Omeprazole | 2007 |
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
Topics: Adult; Aged; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Young Adult | 2009 |
Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Topics: Chemotherapy, Adjuvant; Enzyme Inhibitors; Famotidine; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Histamine H2 Antagonists; Humans; Injections; Length of Stay; Male; Omeprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Secondary Prevention | 2012 |
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric Mucosa; Gastroscopy; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Postoperative Hemorrhage; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms; Stomach Ulcer; Wound Healing | 2012 |
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).
Topics: Algorithms; Benzamides; Diterpenes; Dose-Response Relationship, Drug; Dyspepsia; Famotidine; Gastroesophageal Reflux; Guideline Adherence; Humans; Japan; Morpholines; Omeprazole; Proton Pump Inhibitors; Treatment Outcome; Upper Gastrointestinal Tract | 2012 |
Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Drug Antagonism; Famotidine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Omeprazole; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2012 |
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2013 |
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Aspirin; Chi-Square Distribution; Clopidogrel; Cross-Over Studies; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Famotidine; Female; Histamine H2 Antagonists; Humans; Israel; Linear Models; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.
Topics: Acetamides; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Famotidine; Female; Humans; Male; Medication Adherence; Middle Aged; Omeprazole; Piperidines; Pyridines; Republic of Korea; Severity of Illness Index; Treatment Outcome | 2015 |
Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
Topics: Animals; Antacids; Anti-Ulcer Agents; Area Under Curve; Cats; Cross-Over Studies; Famotidine; Half-Life; Hydrogen-Ion Concentration; Monitoring, Physiologic; Ointments; Omeprazole; Stomach; Tablets | 2015 |
Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open-Label Randomized Crossover Study.
Topics: Adamantane; Adult; Aluminum Hydroxide; Area Under Curve; Cross-Over Studies; Dipeptides; Drug Combinations; Drug Interactions; Famotidine; Female; Healthy Volunteers; Humans; Magnesium Hydroxide; Male; Metabolic Clearance Rate; Omeprazole; Simethicone; Young Adult | 2019 |
The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects.
Topics: Administration, Oral; Adult; Biological Availability; Famotidine; Female; Food-Drug Interactions; Healthy Volunteers; Humans; Janus Kinase 1; Male; Middle Aged; Omeprazole; Protein Kinase Inhibitors; Proton Pump Inhibitors; Pyridines; Tablets; Triazoles; Young Adult | 2019 |
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aspirin; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Risk Factors | 2021 |
A prospective, randomized, placebo-controlled, double-blinded clinical trial comparing the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam alone or in combination with omeprazole or famotidine.
Topics: Animals; Dog Diseases; Dogs; Famotidine; Incidence; Neoplasms; Omeprazole; Piroxicam; Prospective Studies | 2021 |
112 other study(ies) available for omeprazole and famotidine
| Article | Year |
|---|---|
[Clinico-pharmacological evaluation of omeprazole, as a proton pump inhibitor, compared with H2-blockers].
Topics: Adenosine Triphosphatases; Adult; Biological Availability; Drug Tolerance; Famotidine; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Male; Omeprazole; Pepsin A; Tetragastrin | 1992 |
Effects of histamine H2-receptor antagonists and a proton pump inhibitor on the mucosal hydroxyproline content of ethanol-HCl-induced gastric lesions in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Collagen; Ethanol; Famotidine; Gastric Mucosa; Hydrochloric Acid; Hydroxyproline; Male; Omeprazole; Rabeprazole; Rats; Rats, Inbred Strains; Stomach Ulcer | 1992 |
Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
Topics: Adult; Alcoholic Intoxication; Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole; Ranitidine | 1991 |
Medical therapy for gastroesophageal reflux disease. Not all treatments are equal!
Topics: Drug Administration Schedule; Famotidine; Gastroesophageal Reflux; Humans; Omeprazole | 1991 |
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Famotidine; Gastric Acid; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Pantoprazole; Pentagastrin; Stomach; Sulfoxides | 1991 |
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains | 1991 |
Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Esophagitis, Peptic; Famotidine; Gastric Mucosa; Immersion; Lansoprazole; Omeprazole; Peptic Ulcer; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Psychological | 1991 |
Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
Topics: Adult; Aged; Chronic Disease; Cisapride; Esophagitis, Peptic; Esophagus; Famotidine; Female; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Piperidines; Serotonin Antagonists; Stomach | 1991 |
Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.
Topics: Animals; Cell Division; Cells, Cultured; Cimetidine; DNA; Famotidine; Hepatectomy; Histamine H2 Antagonists; Hormones; Liver; Omeprazole; Osmolar Concentration; Ranitidine; Rats; Rats, Inbred F344; Thiazoles | 1989 |
Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
Topics: Animals; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastrins; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Thiazoles | 1989 |
Is there a fundic factor which regulates G cells in the antrum?
Topics: Animals; Dose-Response Relationship, Drug; Famotidine; Gastric Fundus; Gastrins; Male; Omeprazole; Pyloric Antrum; Radioimmunoassay; Rats; Rats, Inbred Strains; Thiazoles | 1989 |
[Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
Topics: Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Depression, Chemical; Famotidine; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Male; Omeprazole; Rabbits; Thiazoles | 1988 |
Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
Topics: Animals; Benzimidazoles; Cimetidine; Famotidine; Gastric Emptying; Gastric Juice; Histamine H2 Antagonists; Male; Omeprazole; Rats; Secretory Rate; Thiadiazoles; Thiazoles | 1985 |
[Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
Topics: Animals; Dogs; Duodenitis; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase; Stomach Ulcer; Thiazoles | 1988 |
[New developments in ulcer therapy: famotidine, omeprazole misoprostol].
Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles | 1986 |
[Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles | 1987 |
[The effects of famotidine and omeprazole on 24-hour intragastric pH of normal subjects].
Topics: Adult; Circadian Rhythm; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Reference Values; Thiazoles | 1988 |
Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
Topics: Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Famotidine; Gastric Acidity Determination; Humans; Imidazoles; Omeprazole; Ranitidine; Thiazoles | 1986 |
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
Topics: Animals; Benzodiazepines; Cell Count; Enterochromaffin Cells; Famotidine; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Omeprazole; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Time Factors | 1995 |
Effect of current direction and K+ on polarization of the frog gastric mucosa proton pump.
Topics: Animals; Anti-Ulcer Agents; Anura; Famotidine; Gastric Mucosa; Imidazoles; Membrane Potentials; Omeprazole; Patch-Clamp Techniques; Potassium; Proton Pumps; Thiocyanates | 1995 |
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats.
Topics: Animals; Famotidine; Gastric Mucosa; Immersion; Leukotrienes; Male; Omeprazole; Peroxidase; Polyethylene Glycols; Prostaglandins; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological; Superoxide Dismutase; Tacrolimus; Xanthine Oxidase | 1994 |
Outcomes of antireflux therapy for the treatment of chronic laryngitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Famotidine; Female; Gastroesophageal Reflux; Humans; Laryngitis; Laryngoscopy; Male; Middle Aged; Omeprazole; Prospective Studies; Sleep; Treatment Outcome | 1995 |
Mucosal regeneration of gastric ulcer confirmed by electronic endoscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Electronics, Medical; Famotidine; Female; Gastric Mucosa; Gastroscopy; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Regeneration; Stomach Ulcer | 1995 |
Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Monitoring, Physiologic; Omeprazole | 1995 |
Drug interactions of H2-receptor antagonists.
Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline | 1994 |
Peptic ulcer disease in adolescence: changing concepts in the age of Helicobacter pylori.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Ranitidine; Recurrence; Sucralfate | 1994 |
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Piperidines; Proton Pump Inhibitors; Stomach Ulcer; Ultrasonography, Interventional; Wound Healing | 1994 |
[Maintenance therapy with antiulcer drugs: review of 71 cases].
Topics: Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Carbonates; Cross-Over Studies; Duodenal Ulcer; Famotidine; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Risk Factors; Time Factors | 1995 |
Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Topics: Animals; Cimetidine; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Guinea Pigs; Heart Atria; Heart Rate; Histamine; Histamine H2 Antagonists; Infusions, Intravenous; Male; Omeprazole; Pyrimidinones; Rats; Rats, Wistar; Thiazoles | 1993 |
Hyperplastic polyps following treatment of acute gastric ulcers.
Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Polyps; Sclerotherapy; Stomach Neoplasms; Stomach Ulcer | 1994 |
Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
Topics: Animals; Blotting, Western; Cimetidine; Drug Interactions; Famotidine; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Male; Microscopy, Electron; Omeprazole; Parietal Cells, Gastric; Rabbits | 1994 |
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Benzodiazepines; Duodenal Ulcer; Epirizole; Ethanol; Famotidine; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Indomethacin; Male; Omeprazole; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stomach Ulcer; Stress, Physiological | 1994 |
Hepatitis following treatments with famotidine and then cimetidine.
Topics: Chemical and Drug Induced Liver Injury; Cimetidine; Duodenal Ulcer; Famotidine; Fatty Liver; Female; Humans; Middle Aged; Omeprazole | 1994 |
[High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].
Topics: Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Famotidine; Gastrointestinal Hemorrhage; Humans; Magnesium Hydroxide; Omeprazole; Peptic Ulcer Hemorrhage; Pirenzepine; Recurrence; Retrospective Studies; Survival Rate | 1994 |
Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over study.
Topics: Adult; Aged; Esophagitis; Esophagus; Famotidine; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole | 1994 |
Role of histamine2 receptor in increased expression of rat gastric H(+)-K(+)-ATPase alpha-subunit induced by omeprazole.
Topics: Animals; Drug Synergism; Famotidine; H(+)-K(+)-Exchanging ATPase; Male; Omeprazole; Rats; Rats, Wistar; Receptors, Histamine H2; RNA, Messenger; Stomach | 1993 |
The relationship between endoscopic findings of gastric ulcer scar and ulcer relapse.
Topics: Adult; Aged; Aged, 80 and over; Famotidine; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Omeprazole; Recurrence; Stomach Ulcer; Wound Healing | 1993 |
Effect of inhibitors of gastric secretion on polarization of gastric potential by voltage clamping.
Topics: Animals; Famotidine; Gastric Acid; Gastric Mucosa; In Vitro Techniques; Kinetics; Membrane Potentials; Models, Biological; Omeprazole; Potassium; Rana pipiens; Sodium Chloride; Sodium-Potassium-Exchanging ATPase; Stomach | 1993 |
Efficacy of famotidine for omeprazole-refractory gastric ulcer.
Topics: Adult; Famotidine; Humans; Male; Omeprazole; Stomach Ulcer | 1993 |
Efficacy of long-term therapy with low doses of omeprazole in the control of gastric acid secretion in Zollinger-Ellison syndrome patients.
Topics: Adult; Drug Administration Schedule; Famotidine; Female; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Zollinger-Ellison Syndrome | 1993 |
The liver regenerative response elicited by antisecretory agents in partially hepatectomized rats: a comparison between omeprazole and famotidine.
Topics: Animals; Anti-Ulcer Agents; Famotidine; Gastrins; Hepatectomy; Kidney Function Tests; Liver Function Tests; Liver Regeneration; Male; Mitotic Index; Omeprazole; Organ Size; Rats; Rats, Wistar | 1995 |
Regulation of peptide YY homeostasis by gastric acid and gastrin.
Topics: Animals; Dogs; Famotidine; Female; Gastric Acid; Gastrinoma; Gastrins; Gastrointestinal Hormones; Gene Expression; Homeostasis; Humans; Male; Mice; Mice, Nude; Omeprazole; Peptide YY; Peptides; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1996 |
Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bicarbonates; Capsaicin; Duodenum; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Lansoprazole; Male; Neurons, Afferent; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Vasoactive Intestinal Peptide | 1996 |
The effects of acid inhibitors on gastric mucus.
Topics: Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Omeprazole | 1996 |
The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach.
Topics: Animals; Anti-Ulcer Agents; Dinoprostone; Enzyme Inhibitors; Famotidine; Gastric Mucins; Glycoproteins; Histamine H2 Antagonists; Male; Omeprazole; Parietal Cells, Gastric; Rats; Rats, Wistar | 1996 |
[Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Famotidine; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Indomethacin; Lansoprazole; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley | 1996 |
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Animals; Anti-Ulcer Agents; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Injections, Intravenous; Lansoprazole; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stress, Physiological | 1996 |
Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.
Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famotidine; Female; Gastrinoma; Gastrins; Immunohistochemistry; Indium Radioisotopes; Injections, Subcutaneous; Microscopy, Electron; Octreotide; Omeprazole; Pancreas; Pancreatic Neoplasms; Radioimmunoassay; Radionuclide Imaging; Receptors, Somatostatin; Somatostatin; Sucralfate | 1997 |
Effects of cimetidine on acute gastric mucosal injury induced by ischemia-reperfusion in rats.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Erythrocyte Membrane; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Lipid Peroxidation; Male; Omeprazole; Rats; Rats, Wistar; Reperfusion Injury; Stomach Diseases | 1997 |
H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Wistar; Weight Gain | 1997 |
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lansoprazole; Male; Middle Aged; Neutrophils; Omeprazole; Peroxidase; Proton Pump Inhibitors; Stomach Ulcer | 1997 |
Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Carcinoid Tumor; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Stomach Neoplasms; Time Factors | 1998 |
Omeprazole, nitrendipine, famotidine and stress-induced ulcers.
Topics: Animals; Anti-Ulcer Agents; Calcium Channel Blockers; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Male; Nitrendipine; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological | 1997 |
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
Topics: Administration, Oral; Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Drug Utilization; Famotidine; Feedback; Hong Kong; Hospitals, Teaching; Humans; Infusions, Intravenous; Medical Audit; Nizatidine; Omeprazole; Practice Patterns, Physicians'; Ranitidine | 1998 |
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |
Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Epoprostenol; Famotidine; Gastric Mucosa; Genes, Immediate-Early; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar; Regional Blood Flow; Stress, Physiological | 1999 |
Helicobacter pylori infection and persistent hyperemesis gravidarum.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hyperemesis Gravidarum; Omeprazole; Penicillins; Peptic Ulcer; Pregnancy; Pregnancy Complications, Infectious; Proton Pump Inhibitors; Ranitidine | 1999 |
Optimum management of mild esophagitis in Japan.
Topics: Anti-Ulcer Agents; Disease Management; Esophagitis, Peptic; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Japan; Omeprazole; Proton Pump Inhibitors | 1999 |
[Role of 24 hour intraesophageal pH monitoring in diagnosis of gastroesophageal reflux and assessment of drug effectiveness].
Topics: Adult; Anti-Ulcer Agents; Circadian Rhythm; Esophagus; Famotidine; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 1999 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Tinidazole | 2000 |
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Cell Culture Techniques; Endothelium; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Neutrophils; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer | 2000 |
Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Aspirin; Disease Models, Animal; Drug Evaluation, Preclinical; Famotidine; Female; Free Radical Scavengers; Gastric Acidity Determination; Lipid Peroxidation; Male; Melatonin; Omeprazole; Rats; Stomach Ulcer | 2001 |
[Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer].
Topics: Acid-Base Equilibrium; Acidosis; Adult; Anti-Ulcer Agents; Bicarbonates; Famotidine; Female; Gastric Acid; Gastric Juice; Humans; Male; Omeprazole; Peptic Ulcer; Time Factors | 2001 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretation, Statistical; Disaccharides; Duodenal Diseases; Esophageal Diseases; Famotidine; Female; Humans; Lansoprazole; Male; Mannitol; Mesalamine; Middle Aged; Omeprazole; Permeability; Proton Pumps; Retrospective Studies; Stomach Diseases; Treatment Outcome | 2001 |
Antiulcerogenic effect of Hippophae rhamnoides L.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Famotidine; Fruit; Indomethacin; Male; Misoprostol; Omeprazole; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Rosales; Stomach Ulcer; Stress, Physiological | 2001 |
Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Circadian Rhythm; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Heterozygote; Homozygote; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors | 2002 |
Wine stimulates gastric acid secretion in isolated rabbit gastric glands via two different pathways.
Topics: Animals; Calcium; Chelating Agents; Egtazic Acid; Enzyme Inhibitors; Ethanol; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; In Vitro Techniques; Omeprazole; Rabbits; Wine | 2002 |
[Treatment of NSAIDs induced ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Famotidine; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2002 |
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Middle Aged; Mucins; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Ranitidine; Receptor, Muscarinic M1; Receptors, Muscarinic; Stomach Ulcer | 2002 |
Primary hyperparathyroidism with duodenal ulcer and H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Aged; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism; Male; Omeprazole; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Rabeprazole | 2002 |
[Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Epithelium; Famotidine; Gastric Mucosa; Lansoprazole; Male; Microcirculation; Octreotide; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer; Treatment Outcome | 2002 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Drug Interactions; Famotidine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tacrolimus | 2002 |
Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?
Topics: Anti-Ulcer Agents; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Injections, Intravenous; Omeprazole; Proton Pump Inhibitors | 2004 |
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydrogen-Ion Concentration; Male; Mast Cells; Omeprazole; Premedication; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological | 2004 |
Effects of omeprazole, famotidine, and ranitidine on the enzyme activities of carbonic anhydrase from bovine stomach in vitro and rat erythrocytes in vivo.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cattle; Erythrocytes; Esterases; Famotidine; In Vitro Techniques; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach | 2004 |
[Problems of excretory insufficiency of the pancreas].
Topics: Adolescent; Adult; Aged; Famotidine; Feces; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pain; Pancreas; Pancreatic Elastase; Pancreatic Function Tests; Pancreatitis; Treatment Outcome | 2004 |
Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Omeprazole | 2005 |
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Benzimidazoles; Dogs; Dose-Response Relationship, Drug; Famotidine; Food Deprivation; Gastric Acidity Determination; Gastric Juice; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Reference Values; Sulfoxides | 2005 |
Attenuation of acid induced oesophagitis in VR-1 deficient mice.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Capsaicin; Endocytosis; Esophagitis; Famotidine; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Omeprazole; Peroxidase; Receptors, Neurokinin-1; Severity of Illness Index; TRPV Cation Channels | 2006 |
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Topics: Acute Disease; Anti-Ulcer Agents; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Humans; Octreotide; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pirenzepine; Proton Pump Inhibitors | 2005 |
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Drug Tolerance; Famotidine; Female; Gastric Acidity Determination; Gastrins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Piperidines; Pneumonia, Aspiration; Preanesthetic Medication; Proton Pump Inhibitors; Rabeprazole | 2005 |
A novel gastric lesion model induced in rats by partial gastric vascular ligation.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Ligation; Male; Omeprazole; Rats; Rats, Wistar; Stomach Diseases; Time Factors | 2005 |
[Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease].
Topics: Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Follow-Up Studies; Gastric Acid; Gastric Emptying; Gastric Mucosa; Humans; Male; Middle Aged; Omeprazole; Stomach; Treatment Outcome | 2006 |
Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cardiac Surgical Procedures; Combined Modality Therapy; Esophagus; Famotidine; Female; Gastric Acid; Gastrointestinal Hemorrhage; Heart Diseases; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Perioperative Care; Rabeprazole; Stomach; Time Factors; Treatment Outcome | 2006 |
Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection.
Topics: Animals; Anti-Ulcer Agents; Carnosine; Famotidine; Gastric Acid; Gastric Mucosa; Gene Expression Regulation; HSP72 Heat-Shock Proteins; Hydrochloric Acid; Hydrogen-Ion Concentration; Male; Mucous Membrane; Omeprazole; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Zinc Compounds; Zinc Sulfate | 2006 |
Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Epidemiologic Methods; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2007 |
Promotion of cutaneous wound healing by famotidine in Wistar rats.
Topics: Analysis of Variance; Animals; Collagen; Famotidine; Granulation Tissue; Omeprazole; Rats; Rats, Wistar; Skin; Sucralfate; Wound Healing | 2007 |
[Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Famotidine; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Ranitidine; Russia | 2007 |
[Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Topics: Antacids; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Pirenzepine; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2009 |
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Topics: 16,16-Dimethylprostaglandin E2; Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsaicin; Cimetidine; Disease Models, Animal; Enterobacteriaceae; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Intestine, Small; Male; Mucin-2; Nitric Oxide Synthase Type II; Omeprazole; Peptic Ulcer; Peroxidase; Phenylpropionates; Piperidines; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensory Receptor Cells | 2010 |
[Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene].
Topics: Aged; Alcoholism; Esophagitis, Peptic; Famotidine; Histamine H2 Antagonists; Humans; Intestinal Absorption; Magnesium; Magnesium Deficiency; Male; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Tetany; TRPM Cation Channels | 2011 |
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Magnesium Deficiency; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome | 2010 |
Inhibitors of acid secretion can benefit gastric wound repair independent of luminal pH effects on the site of damage.
Topics: Animals; Epithelium; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred C57BL; Omeprazole; Stomach; Wound Healing | 2012 |
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays | 2012 |
The elegance of the gastric mucosal barrier: designed by nature for nature.
Topics: Animals; Famotidine; Female; Gastric Acid; Male; Omeprazole; Stomach; Wound Healing | 2012 |
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Interactions; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Omeprazole; Peroxidase; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine | 2012 |
Gastric acid inhibitors may prevent/heal oxyntic lesions by reducing blood demand.
Topics: Animals; Famotidine; Female; Gastric Acid; Male; Omeprazole; Stomach; Wound Healing | 2013 |
Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel.
Topics: Acute Coronary Syndrome; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Famotidine; Female; Humans; Male; Omeprazole; Platelet Aggregation Inhibitors; Ticlopidine | 2012 |
Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Thromboembolism | 2014 |
In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
Topics: Biological Transport; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Line; Chemokine CCL26; Diltiazem; Egtazic Acid; Eosinophilic Esophagitis; Epithelial Cells; Esophageal Mucosa; Famotidine; Female; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Interleukin-4 Receptor alpha Subunit; Male; Omeprazole; Primary Cell Culture; Proton Pump Inhibitors; Proton Pumps; Ranitidine; RNA, Messenger; Signal Transduction; Th2 Cells; Verapamil | 2021 |
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Topics: Animals; Famotidine; Gastroesophageal Reflux; Gastrointestinal Neoplasms; Humans; Omeprazole; Ranitidine; United States | 2021 |
Evaluation of a long-acting injectable formulation of omeprazole in healthy dogs.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Dogs; Famotidine; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Omeprazole; Prospective Studies | 2022 |
Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies.
Topics: COVID-19; Famotidine; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors | 2022 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |